Impensa® is a healthcare supply chain data services partner that aims to provide transparency and visibility for actionable analytics in the healthcare industry. The platform offers product identification, matching, and data enhancement services to enable healthcare providers, consulting firms, and vendors to leverage medical product data to support their objectives. Impensa® provides access to 8.0+ million curated healthcare products, product file identification and matching across siloed platforms, standardization across multi-entities with disparate systems, and attributes such as 5-level categorization, packaging, device characteristics, and clinical noun. Additionally, the products are bar-coded and enhanced with UNSPSC, HCPCS, RevCodes & GTIN’s, and product benchmarks for pricing guidance and to support Opportunity Analytics. Founded in 2018, Impensa® operates in the industries of enterprise, financial services, and health care. Currently, there is no available information on the company's headquarters, last investment, or the investors involved in the last investment round. The company's extensive database and focus on transforming healthcare supply chain data set it as an interesting player in the healthcare data analytics space and this could attract investor interest. However, further details on the company's financials, traction, and growth projections would be essential to fully assess its potential for investment.
There is no investment information
No recent news or press coverage available for Impensa®.